Plant-derived glucocerebrosidase
From Proteopedia
(New page: <StructureSection load="2v3f" size="400" color="" frame="true" spin="on" Scene='2v3f/Cv/5' align="right" caption= > 200px ===ACID-BETA-GLUCOSIDASE PRODUCED IN CA...) |
|||
| Line 2: | Line 2: | ||
[[Image:2v3f.png|left|200px]] | [[Image:2v3f.png|left|200px]] | ||
| - | ===ACID-BETA-GLUCOSIDASE PRODUCED IN CARROT CELLS=== | + | ===ACID-BETA-GLUCOSIDASE PRODUCED IN CARROT CELLS ([[2v3f]])=== |
(see also [[Treatment of Gaucher disease]]) | (see also [[Treatment of Gaucher disease]]) | ||
| Line 51: | Line 51: | ||
[[Category: Polymorphism]] | [[Category: Polymorphism]] | ||
[[Category: Sphingolipid metabolism]] | [[Category: Sphingolipid metabolism]] | ||
| + | <br /> | ||
| + | Created with the participation of [[User:Joel L. Sussman|Joel L. Sussman]]. | ||
Revision as of 11:09, 11 June 2012
| |||||||||||
About this Structure
2V3F is a 2 chains structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Shaaltiel Y, Bartfeld D, Hashmueli S, Baum G, Brill-Almon E, Galili G, Dym O, Boldin-Adamsky SA, Silman I, Sussman JL, Futerman AH, Aviezer D. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system. Plant Biotechnol J. 2007 Sep;5(5):579-90. Epub 2007 May 24. PMID:17524049 doi:10.1111/j.1467-7652.2007.00263.x
Created with the participation of Joel L. Sussman.
Proteopedia Page Contributors and Editors (what is this?)
Categories: Glucosylceramidase | Homo sapiens | Aviezer, D. | Bartfeld, D. | Baum, G. | Boldin-Adamsky, S A. | Brill-Almon, E. | Dym, O. | Futerman, A H. | Galili, G. | Hashmueli, S. | Ispc, Israel Structural Proteomics Center. | ISPC, Israel Structural Proteomics Center. | ISPC | Shaaltiel, Y. | Silman, I. | Sussman, J L. | Acid-beta-glucosidase | Alternative initiation | Alternative splicing | Disease mutation | Gaucher disease | Glycoprotein | Glycosidase | Hydrolase | Lipid metabolism | Lysosome | Membrane | N-butyl-deoxynojirimycin | Pharmaceutical | Polymorphism | Sphingolipid metabolism
